Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
2.03M
-
Shares change
-
+505K
-
Total reported value, excl. options
-
$33M
-
Value change
-
+$8.65M
-
Number of buys
-
28
-
Number of sells
-
-10
-
Price
-
$16.26
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q2 2017
44 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q2 2017.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.03M shares
of 22.2M outstanding shares and own 9.15% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (600K shares), Rock Springs Capital Management LP (540K shares), ARMISTICE CAPITAL, LLC (282K shares), BlackRock Inc. (175K shares), VANGUARD GROUP INC (79.4K shares), RENAISSANCE TECHNOLOGIES LLC (75.4K shares), BAKER BROS. ADVISORS LP (57.8K shares), NORTHERN TRUST CORP (50.1K shares), STATE STREET CORP (33.2K shares), and GEODE CAPITAL MANAGEMENT, LLC (32.2K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.